🇺🇸 FDA
Patent

US 6399087

Propofol formulation with enhanced microbial inhibition

expired A61KA61K31/05A61K47/24

Quick answer

US patent 6399087 (Propofol formulation with enhanced microbial inhibition) held by Amphastar Pharmaceuticals, Inc. expires Mon May 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Amphastar Pharmaceuticals, Inc.
Grant date
Tue Jun 04 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/05, A61K47/24, A61K47/44, A61K9/0019